Literature DB >> 3371725

Tripotassium dicitrato bismuthate on unhealed duodenal ulcers.

F Konikoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3371725      PMCID： PMC1433552          DOI： 10.1136/gut.29.4.551

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.

Authors:  C A McNulty; J C Gearty; B Crump; M Davis; I A Donovan; V Melikian; D M Lister; R Wise
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

2.  Peptic ulcer disease: a bacterial infection?

Authors:  R B Hornick
Journal:  N Engl J Med       Date:  1987-06-18       Impact factor: 91.245

3.  Campylobacter pyloridis--a new factor in peptic ulcer disease?

Authors:  B J Rathbone; J I Wyatt; R V Heatley
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

4.  Campylobacter pyloridis and gastritis.

Authors:  B J Marshall
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

5.  Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers.

Authors:  G Bianchi Porro; F Parente; M Lazzaroni
Journal:  Gut       Date:  1987-07       Impact factor: 23.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.